AXON — what changed in the latest 10-Q

Text added vs the prior filing · source: 10-Q · 2026-08-06

• Our revenues for the six months ended June 30, 2026 were $1.7 billion, an increase of $439.6 million, or 34.6%, from the six months ended June 30, 2025. We had income from operations of $76.0 million, compared to loss from operations of $9.8 million for the same period in the prior year. Gross margi…

• On February 20, 2026, the Supreme Court determined that tariffs imposed under the International Emergency Economic Powers Act (“IEEPA”) were unauthorized. During the three months ended June 30, 2026, we received $47.4 million in refunds. Of this amount, $18.1 million had been previously expensed in …

• Three Months Ended June 30, 2026 Compared to the Three Months Ended June 30, 2025

• Other SG&A expenses increased $27.9 million in comparison to the prior year June 30, 2025 comparable period, primarily driven by increased advisory expenses of $8.7 million, increased travel expenses of $5.4 million, and increased technology license expenses of $4.4 million as a result of the contin…

• Stock-based compensation expense increased $7.2 million in comparison to the prior year June 30, 2025 comparable period, primarily driven by increased headcount.

Text removed vs the prior filing · source: 10-Q · 2026-05-07

• On February 20, 2026, the Supreme Court determined that tariffs imposed under the International Emergency Economic Powers Act (“IEEPA”) were unauthorized. The ruling did not provide guidance regarding the recovery of amounts previously remitted. As of March 31, 2026, we have not recorded a benefit f…

• Three Months Ended March 31, 2026 Compared to the Three Months Ended March 31, 2025

• Other SG&A expenses increased $14.6 million in comparison to the prior year March 31, 2025 comparable period, primarily driven by an increase in professional and consulting expenses of $9.1 million.

• Other R&D expenses increased $16.6 million in comparison to the prior year March 31, 2025 comparable period, partially driven by an increase in professional and consulting expenses of $6.8 million.

• (1)Interest expense increased in comparison to the prior year March 31, 2025 comparable period primarily as a result of the issuance of the Senior Notes in March 2025, as discussed further within Note 8.

Text added vs the prior filing · source: 10-Q · 2026-08-06

• There have been no other material changes in our primary risk exposures or management of risks since the prior year.

• There have been no other material changes in our primary risk exposures or management of risks since the prior year.

Text added vs the prior filing · source: 10-Q · 2026-08-06

• As disclosed in Part II, Item 9A of our 2025 Annual Report on Form 10-K, we previously identified a material weakness in our internal control over financial reporting related to revenue recognition for customer contracts. Specifically, the Company did not design and maintain controls to update its r…

• There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended June 30, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial re…

Text removed vs the prior filing · source: 10-Q · 2026-05-07

• Remediation Efforts to Address the Material Weakness Related to Revenue Recognition

• With respect to this material weakness, management, under the oversight of the Audit Committee, continues to execute the remediation plan as disclosed in Part II, Item 9A of our 2025 Annual Report on Form 10-K. We have completed the design and implementation of control activities to i) periodically …

• We expect to conclude that the material weakness is remediated once we determine that the applicable controls have operated effectively for a sufficient period of time.

• There have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the quarter ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, our internal control over financial r…

Text added vs the prior filing · source: 10-Q · 2026-08-06

• Jeffrey Kunins, Chief Product Officer and Chief Technology Officer

• (1)Trading arrangement was originally adopted on March 4, 2026.

Text removed vs the prior filing · source: 10-Q · 2026-05-07

• (1)Trading arrangement was originally adopted on December 17, 2025.

• (2)Mr. Fields was appointed as an officer, as defined in Rule 16a-1(f) under the Exchange Act, effective January 1, 2026. On March 9, 2026, he terminated this trading arrangement originally adopted on August 19, 2025. As Mr. Fields was not an officer subject to the disclosure requirements of Item 40…